FinancialContent

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

18.96 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Beta Bionics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Keep an eye on the top gainers and losers in Friday's session. ↗
Via Chartmill
The market is filled with gapping stocks in Friday's session. ↗
Via Chartmill
Friday's pre-market session: top gainers and losers ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
News headline image
Earnings Scheduled For October 28, 2025 ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 6 Analysts Discuss Beta Bionics Stock ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 29, 2025 ↗
 
Via Benzinga
News headline image
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
The Insider Report: The Bears Have Been Poked – Will They Fall Back Asleep? ↗
 
Via Benzinga
News headline image
Beta Bionics Announces Participation at Upcoming Investor Conferences
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Beta Bionics (BBNX) Q3 2025 Earnings Transcript ↗
Beta Bionics (BBNX) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Earnings Supply Chain
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Wondering what's happening in today's after-hours session? ↗
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
Beta Bionics Inc (NASDAQ:BBNX) Tops Q3 2025 Revenue Estimates and Raises Full-Year Guidance ↗
Beta Bionics (BBNX) beat Q3 2025 revenue estimates and raised its full-year guidance. The medical device company reported strong user growth and a narrower-than-expected loss. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Demystifying Beta Bionics: Insights From 5 Analyst Reviews ↗
 
Via Benzinga
News headline image
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Forecasting The Future: 4 Analyst Projections For Beta Bionics ↗
 
Via Benzinga
News headline image
Beta Bionics Announces Participation at Upcoming Investor Conferences
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics (BBNX) Q2 Revenue Soars 54% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Beta Bionics BBNX Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Beta Bionics Inc (NASDAQ:BBNX) Surpasses Q2 2025 Estimates and Raises Full-Year Guidance ↗
Beta Bionics (BBNX) beats Q2 2025 revenue and EPS estimates, raises full-year guidance. Shares surge 5.7% as iLet Bionic Pancreas and new insulin pump drive growth. 
Via Chartmill
News headline image
Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns ↗
Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) fell 5.54% on Thursday to close at $3.92, before rebounding 14.29% in after-hours trading to $4.48, amid concerns of a potential NASDAQ delisting. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
From Beta Bionics, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >